Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
takinib (EDHS-206)
i
Other names:
EDHS-206
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Duke University
Drug class:
TAK1 inhibitor
Related drugs:
‹
NG25 (2)
TL-1-85 (1)
NG25 (2)
TL-1-85 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Melanoma
NRAS mutation
Melanoma
trametinib + EDHS-206
Sensitive: D – Preclinical
trametinib + EDHS-206
Sensitive
:
D
trametinib + EDHS-206
Sensitive: D – Preclinical
trametinib + EDHS-206
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.